A new drug compound could combat tough-to-treat melanoma
Melanoma is commonly caused by the damaging effects of ultraviolet light—from sources like sunlight and tanning beds—on the DNA of skin cells. This UV damage can activate genes that encourage precancerous cells to further mutate into full-blown skin cancer. At the same time, UV damage can turn off other genes that would normally prevent tumor growth. With enough wrongly flipped switches, cancer can flourish. And melanoma is certainly flourishing. This year alone, 96,480 new instances of melanoma will be diagnosed in the United States and 7,230 Americans will die from the disease.
With so many people affected by melanoma, scientists are on the hunt for better ways to screen for melanoma risk and treat the most lethal types of skin cancer. One particularly voracious type of melanoma, caused by mutation of a gene called NRAS (which instructs cells to produce a protein of the same name, NRAS), drives 25 percent of skin cancers.
“There are immunotherapies and targeted therapies that have shown huge improvements for patients with melanoma,” said Rutao Cui, a Boston University School of Medicine professor of pharmacology and dermatology. “However, for patients with NRAS mutations, they don’t have very useful or very effective treatment strategies.”
Now, an international research team led by Cui has discovered a new way to stop the progression of melanoma by NRAS mutations with the flip of a genetic switch. Their findings were published January 31, 2019, in Cell.
Inside our bodies, proteins like NRAS play the role of dominoes, interacting with one another to switch other important gene activities on or off. The researchers set out in search of a way to interrupt the process in which mutated NRAS can instigate the growth of skin cancer. Since targeting the NRAS gene—just one of several dominoes in this type of skin cancer pathway—has proven to be so difficult, the researchers were determined to find another approach.
For NRAS to trigger cancer development, it first needs to be activated by another protein in the body. Until now, it’s been unknown exactly which protein is responsible for activating NRAS. But after testing the effect of several different proteins on the activity of NRAS, the team zeroed in on a likely culprit, a protein by the name of STK19.
STK19 is not a newly discovered protein in its own right, but its purpose has not been known until now. Cui’s team found that STK19 appears to work as an “on” switch for NRAS—activating production of NRAS proteins which, in turn, trigger the toppling of several other genetic dominoes downstream.
The researchers also found that, unlike NRAS, they could disable the STK19 gene and greatly diminish its ability to set the skin cancer sequence in motion.
Together, the team designed a new drug compound to shut down the effect of STK19 on NRAS. Then, testing its effect on skin cells cultured in petri dishes and in animal models, they proved that their compound can block NRAS activation and prevent melanoma from developing.
Cui says that this result is exciting not just for melanoma, but for other cancers as well. While the relationship between STK19 and NRAS may be particular to skin cancer, the approaches the team used to identify and block key activating proteins can be applied to find new treatments for similarly difficult-to-cure cancers.
Now the research team is looking to take their research to clinical trials to test out the STK19 inhibitor in humans, and hopefully, someday make it available as a targeted therapy to combat NRAS-driven melanomas.
In the meantime, Cui says that much work still needs to be done to not only create better and more precise treatments for patients suffering with melanoma, but also to alert vulnerable populations about the risk factors associated with the cancer.
“We need more monitoring for early diagnosis and full-body examinations for problematic spots,” says Cui, “and more proactive strategies for patients [at the highest risk of developing melanoma] to prevent cancer progression and metastasis.”
Learn more: Shutting Down Skin Cancer
The Latest on: Skin cancer
via Google News
The Latest on: Skin cancer
- Bloomfield to Offer Free Skin Cancer Screenings on April 17, 2019 at 10:17 am
The Bloomfield Department of Health and Human Services is offering free skin cancer screenings from 9 a.m. to 11 a.m. on Tuesday, April 23 in the Public Health Nursing Office, 1 Municipal Plaza, Lower ... […]
- Eating just one slice of bacon a day linked to higher risk of colorectal cancer, study says on April 17, 2019 at 9:35 am
In the United States it is the third most common cancer, excluding skin cancers, and around 51,020 deaths are expected to occur due to colorectal cancer in 2019, according to the American Cancer ... […]
- Be Skin Cancer Aware with Advanced Dermatology on April 17, 2019 at 9:25 am
Skin Cancer has affected a lot of us here on the Gulf Coast. Dr. Thomas Bender at Advanced Dermatology spoke with Chelsey about the different types of Skin Cancer that are most common and more ... […]
- Skin Cancer Physicians Dr. Ben Wiese and Dr. Lize Wiese to Speak About Skin Cancer Awareness in Honor of Skin Cancer Awareness Month, May 2019 on April 17, 2019 at 9:13 am
(MENAFN - Newswire.com LLC) KELOWNA, British Columbia, April 17, 2019 (Newswire.com) - Dr. Ben Wiese and Dr. Lize Wiese of the Kelowna Skin Cancer Screening Clinic in Kelowna, British Columbia ... […]
- Doctor wants you to pay attention to your skin on April 17, 2019 at 9:03 am
Sancy Leachman is waging a war on melanoma. Midway through her talk at the Columbia Forum speaker series at Baked Alaska on Tuesday night, she paused and asked who in the audience had ever had skin ... […]
- Fueling the Fight supports cancer patients on April 17, 2019 at 7:39 am
A local family has teamed up with Cancer Perks to raise funds, bring awareness of an often-overlooked dangerous skin cancer, and to keep alive the memory of their loved one. Mindy Rohr, 32, a mother ... […]
- Melanoma Monday: The fight against skin cancer begins in your head – act now on April 17, 2019 at 4:41 am
A melanoma skin cancer campaign has been launched to raise awareness and promote the prevention, early detection and treatment of the commonest skin-related cause of death worldwide. Monday 6 May will ... […]
- Blood pressure drug linked to increased chance of skin cancer on April 17, 2019 at 12:20 am
The alert, issued on 15 April, follows two Danish studies that found an association between long-term use of the diuretic, hydrochlorothiazide, and three varieties of non-melanoma skin cancer. The ... […]
- $12M NIH grant to study rare, aggressive skin cancer on April 16, 2019 at 12:37 pm
A multidisciplinary team from University of Washington and Fred Hutchinson Cancer Research Center has received a five-year, $12 million grant to study Merkel cell carcinoma, a deadly form of skin ... […]
- Skin cancer cases on the rise and it's not just melanoma you need to keep an eye on on April 12, 2019 at 10:38 pm
SAN FRANCISCO (KGO) -- Skin cancer is the most common cancer on earth, and according to new research, it's not going anywhere any time soon. According to the American Cancer Society melanoma, one ... […]
via Bing News